Jeffrey Brewer couldn’t accept the limits on technology when his son first was diagnosed with diabetes.
Back in 2002, commercial airliners could almost land themselves and nuclear plants were automated. Yet the process of measuring glucose blood levels and injecting insulin were still determined by patients and families who were forced to do the math and administer the life-saving medicine themselves.
That frustration pushed the start-up veteran into a career change – focusing his energy and efforts on treating diabetes.
According to Bigfoot Biomedical, Brewer would be known as the “Father of the Artificial Pancreas,” the project he launched in his time as a volunteer, donor, and international board member for the Juvenile Diabetes Research Foundation, where he served as CEO from 2011 to 2014.
But advances in mobile technology and glucose monitoring led Brewer back into the start-up world, this time heading up Bigfoot Biomedical.
The start-up is building a device around a “hack” performed by Chief Product Officer Bryan Mazlish that allowed him to safely monitor his own son’s diabetes through his cell phone.
Now Bigfoot Biomedical is working to build a network-based solution to diabetes management.